Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Adagio Medical Holdings, Inc. (ADGM) is the issuer in an amended beneficial-ownership report by Perceptive Advisors LLC, Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd. and C2 Life Sciences LLC. Perceptive Advisors and Edelman each reported beneficial ownership of 523,356 shares (44.4%); the Master Fund reported 516,660 shares (43.9%), and C2 reported 6,696 shares (0.7%). Voting and dispositive power is shared, and the Advisors’ and Edelman’s amounts include attributed holdings rather than separate positions.
The percentages use 983,434 common shares outstanding as of November 11, 2026, and assume exercise of the reporting persons’ warrants for 181,502 shares and director options exercisable within 60 days. The Master Fund holds of record 322,521 common shares and warrants exercisable for 181,502 shares; C2 holds 6,696 common shares of record.
Key Figures
Beneficial ownership attributed to Perceptive Advisors and Joseph Edelman:523,356 shares (44.4%)Master Fund beneficial ownership:516,660 shares (43.9%)C2 beneficial ownership:6,696 shares (0.7%)+4 more
7 metrics
Beneficial ownership attributed to Perceptive Advisors and Joseph Edelman523,356 shares (44.4%)Each reported this amount with shared voting and dispositive power.
Master Fund beneficial ownership516,660 shares (43.9%)Reported by Perceptive Life Sciences Master Fund, Ltd.
C2 beneficial ownership6,696 shares (0.7%)Reported by C2 Life Sciences LLC.
Common shares outstanding983,434 sharesAs of November 11, 2026; used as the basis for the ownership percentages, with the stated exercise assumptions.
Warrants held by reporting persons181,502 sharesWarrants held by the Master Fund; exercise is assumed in the ownership-percentage calculation.
Options held by Keyvan Mirsaeedi-Farahani4,000 shares; 2,916 currently exercisable or exercisable within 60 daysKeyvan Mirsaeedi-Farahani is a managing director at Perceptive Advisors and a member of the issuer’s board.
Options held by Orly Mishan13,333 shares; 9,721 currently exercisable or exercisable within 60 daysOrly Mishan is a managing director at Perceptive Advisors and a member of the issuer’s board.
"Number of Shares Beneficially Owned by Each Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Powerfinancial
"Shared Voting Power 523,356.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Powerfinancial
"Shared Dispositive Power 523,356.00"
Warrantsfinancial
"Warrants exercisable for 181,502 shares of Common Stock"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
Director Optionsfinancial
"such options, together with the options held by Dr. Mirsaeedi-Farahani, the “Director Options”"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many ADGM shares did Perceptive Advisors report beneficially owning?
Perceptive Advisors LLC reported beneficial ownership of 523,356 shares, or 44.4%, with shared voting and dispositive power. Joseph Edelman reported the same amount and percentage; their reported amounts reflect overlapping attribution, not separate blocks of shares.
What holdings and options are included in the ADGM ownership report?
The Master Fund holds of record 322,521 common shares and warrants exercisable for 181,502 shares; C2 holds 6,696 common shares. Keyvan Mirsaeedi-Farahani holds options for 4,000 shares, 2,916 exercisable or exercisable within 60 days; Orly Mishan holds options for 13,333 shares, 9,721 on that basis.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 4)
Adagio Medical Holdings, Inc.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
00534B308
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
00534B308
1
Names of Reporting Persons
Perceptive Advisors LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
523,356.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
523,356.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
523,356.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
44.4 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
00534B308
1
Names of Reporting Persons
Joseph Edelman
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
523,356.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
523,356.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
523,356.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
44.4 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
00534B308
1
Names of Reporting Persons
Perceptive Life Sciences Master Fund, Ltd.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
516,660.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
516,660.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
516,660.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
43.9 %
12
Type of Reporting Person (See Instructions)
CO
SCHEDULE 13G
CUSIP Number(s):
00534B308
1
Names of Reporting Persons
C2 Life Sciences LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
NEW YORK
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
6,696.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,696.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,696.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.7 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Adagio Medical Holdings, Inc.
(b)
Address of issuer's principal executive offices:
26051 Merit Circle, Suite 102, Laguna Hills, CA 92653
Item 2.
(a)
Name of person filing:
The names of the persons filing this report (collectively, the "Reporting Persons") with respect to shares of Common Stock, par value $0.0001 per share (the "Common Stock") of Adagio Medical Holdings, Inc. (the "Issuer") are:
(i) Perceptive Advisors LLC ("Perceptive Advisors")
(ii) Joseph Edelman ("Mr. Edelman")
(iii) Perceptive Life Sciences Master Fund, Ltd. (the "Master Fund")
(iv) C2 Life Sciences LLC ("C2")
(b)
Address or principal business office or, if none, residence:
The address of the principal business office of each of the Reporting Persons is:
51 Astor Place, 10th Floor, New York, NY 10003
(c)
Citizenship:
Perceptive Advisors is a Delaware limited liability company.
Mr. Edelman is a United States citizen.
The Master Fund is a Cayman Islands corporation.
C2 is a New York limited liability company.
(d)
Title of class of securities:
Common Stock, par value $0.0001 per share
(e)
CUSIP No.:
00534B308
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover pages to this Schedule 13G. The ownership percentages are based on 983,434 shares of Common Stock outstanding as of November 11, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 16, 2026, and assume (i) the exercise of warrants held by the Reporting Persons for 181,502 shares of Common Stock (the "Warrants") and (ii) the exercise of the Director Options (as defined below) to the extent exercisable within 60 days.
The Master Fund is the holder of record of (i) 322,521 shares of Common Stock and (ii) Warrants exercisable for 181,502 shares of Common Stock. C2 is the holder of record of 6,696 shares of Common Stock. Perceptive Advisors serves as the investment manager to the Master Fund and C2, and Mr. Edelman is the managing member of Perceptive Advisors. Keyvan Mirsaeedi-Farahani ("Dr. Mirsaeedi-Farahani"), a Managing Director at Perceptive Advisors and a member of the Issuer's board of directors, holds options to purchase a total of 4,000 shares of Common Stock, of which 2,916 shares are currently exercisable or exercisable within 60 days. Orly Mishan ("Ms. Mishan"), a Managing Director at Perceptive Advisors and a member of the Issuer's board of directors, holds options to purchase a total of 13,333 shares of Common Stock, of which 9,721 shares are currently exercisable or exercisable within 60 days (such options, together with the options held by Dr. Mirsaeedi-Farahani, the "Director Options"). Perceptive Advisors has the right to receive the director compensation provided in respect of Dr. Mirsaeedi-Farahani's and Ms. Mishan's board service, including the Director Options, for the benefit of the Master Fund through a partial offset of the management fee. Accordingly, Perceptive Advisors, Mr. Edelman and the Master Fund may be deemed to beneficially own the shares of Common Stock issuable upon exercise of the Director Options, and Perceptive Advisors and Mr. Edelman have voting and investment discretion with respect to, and may be deemed to beneficially own, the shares of Common Stock and Warrants held of record by the Master Fund and C2.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.